Pharmacologic agents in complementary medicine in prostatic disease

I. M. Thompson

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The use of alternative medicine has increased considerably in the last 10 years. Some of the reasons for this trend include limited efficacy of existing treatments, perceived reduction in side effects with alternative treatments, patient's desire to maintain control over their treatment and a desire for a more "natural" treatment. The very high frequency of urologic diseases such as benign prostatic hyperplasia and prostate cancer makes these diseases natural targets of alternative medicine. Although a great number of therapeutic agents have been recommended for urologic diseases, this review examines the most promising for their use in benign prostatic hyperplasia and prostate cancer.

Original languageEnglish (US)
Pages (from-to)427-433
Number of pages7
JournalDrugs of Today
Volume37
Issue number6
StatePublished - 2001

Fingerprint

Prostatic Diseases
Complementary Therapies
Prostatic Neoplasms
Urologic Diseases
Prostatic Hyperplasia
Therapeutics

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology (medical)
  • Pharmacology

Cite this

Pharmacologic agents in complementary medicine in prostatic disease. / Thompson, I. M.

In: Drugs of Today, Vol. 37, No. 6, 2001, p. 427-433.

Research output: Contribution to journalArticle

Thompson, I. M. / Pharmacologic agents in complementary medicine in prostatic disease. In: Drugs of Today. 2001 ; Vol. 37, No. 6. pp. 427-433.
@article{e482509478b94e1a890e2ac0d8cbd911,
title = "Pharmacologic agents in complementary medicine in prostatic disease",
abstract = "The use of alternative medicine has increased considerably in the last 10 years. Some of the reasons for this trend include limited efficacy of existing treatments, perceived reduction in side effects with alternative treatments, patient's desire to maintain control over their treatment and a desire for a more {"}natural{"} treatment. The very high frequency of urologic diseases such as benign prostatic hyperplasia and prostate cancer makes these diseases natural targets of alternative medicine. Although a great number of therapeutic agents have been recommended for urologic diseases, this review examines the most promising for their use in benign prostatic hyperplasia and prostate cancer.",
author = "Thompson, {I. M.}",
year = "2001",
language = "English (US)",
volume = "37",
pages = "427--433",
journal = "Drugs of Today",
issn = "1699-3993",
publisher = "Prous Science",
number = "6",

}

TY - JOUR

T1 - Pharmacologic agents in complementary medicine in prostatic disease

AU - Thompson, I. M.

PY - 2001

Y1 - 2001

N2 - The use of alternative medicine has increased considerably in the last 10 years. Some of the reasons for this trend include limited efficacy of existing treatments, perceived reduction in side effects with alternative treatments, patient's desire to maintain control over their treatment and a desire for a more "natural" treatment. The very high frequency of urologic diseases such as benign prostatic hyperplasia and prostate cancer makes these diseases natural targets of alternative medicine. Although a great number of therapeutic agents have been recommended for urologic diseases, this review examines the most promising for their use in benign prostatic hyperplasia and prostate cancer.

AB - The use of alternative medicine has increased considerably in the last 10 years. Some of the reasons for this trend include limited efficacy of existing treatments, perceived reduction in side effects with alternative treatments, patient's desire to maintain control over their treatment and a desire for a more "natural" treatment. The very high frequency of urologic diseases such as benign prostatic hyperplasia and prostate cancer makes these diseases natural targets of alternative medicine. Although a great number of therapeutic agents have been recommended for urologic diseases, this review examines the most promising for their use in benign prostatic hyperplasia and prostate cancer.

UR - http://www.scopus.com/inward/record.url?scp=0034899021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034899021&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0034899021

VL - 37

SP - 427

EP - 433

JO - Drugs of Today

JF - Drugs of Today

SN - 1699-3993

IS - 6

ER -